BioFingertips

Scientific Social Media for the Global Healthcare Community.

[BioFingertips @biofingertips]

HOT TOPIC OF THE WEEK | Most Viewed Paper on BioFingertips

This week, the paper most viewed on BioFingertips was: “A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.”

A Breakthrough in Pancreatic Cancer Treatment!

Pancreatic cancer is one of the deadliest cancers, largely because tumors quickly develop resistance to existing therapies. A groundbreaking new study shows that simultaneously blocking three key molecular pathways - RAF1, EGFR, and STAT3 - can cause complete and lasting tumor regression with no signs of resistance for over 200 days. Remarkably, the drug combination was well tolerated and showed strong results across multiple tumor models, including patient-derived samples. This research could pave the way for powerful new clinical trials.

Being the most viewed paper reflects what resonated most with healthcare professionals this week.

Read the paper here:

https://t.co/IetXP0J1BU

On BioFingertips, sharing content helps to highlight what the community finds relevant in real time!

#CancerResearch #Oncology #MedicalBreakthrough #ASCO

[BioFingertips @biofingertips]

Cada día se publican miles de papers médicos.

En un contexto de sobrecarga informativa, múltiples fuentes y cada vez menos tiempo disponible, mantenerse actualizado es un verdadero desafío para los profesionales de la salud.

Los invitamos al webinar: “¿Cómo estar actualizado en un océano de información?”

Vamos a conversar sobre:
✔ Cómo reducir el ruido informativo
✔ Estrategias para optimizar el tiempo dedicado al estudio
✔ Curación de contenidos e inteligencia colectiva
✔ Nuevas formas de acceder al conocimiento científico

📅 21 de mayo de 2026
🕖 19:00h (Argentina)
💻 Modalidad Zoom

https://t.co/Ngrt5R54bd

Organiza: BioFingertips

hashtag#Medicina hashtag#EducacionMedicaContinua hashtag#MedicalEducation hashtag#Healthcare hashtag#InformacionCientifica hashtag#BioFingertips

[BioFingertips @biofingertips]

HOT TOPIC OF THE WEEK | Most Liked Paper on BioFingertips

This week, the most liked paper on BioFingertips is: “Prognostic factors for mortality in patients infected with New World hantaviruses: a systematic review and meta-analysis.”

This systematic review and meta-analysis examined prognostic factors for mortality in New World hantavirus infections, analyzing 25 studies involving 7,284 participants.

The authors identified seven factors associated with increased mortality with moderate-to-high certainty: age over 18, female sex, rural residence, elevated creatinine, increased hematocrit, signs of bleeding, and chest radiograph infiltrates.

These findings can help clinicians identify high-risk patients early, supporting timely ICU referral and informed management decisions. The authors also highlight these results as a foundation for developing a future clinical prognostic scoring model to improve patient outcomes.

Being the most liked paper reflects what resonated most with healthcare professionals this week.

On BioFingertips, likes help highlight what the community finds relevant in real time.

Read the paper here:
https://t.co/IUNb9qHook

#Hantavirus #InfectiousDisease #Zoonosis #Prognosis #NewWorldHantavirus #Viral #HemorrhagicFever #EvidenceBasedMedicine
📷

[BioFingertips @biofingertips]

HOT TOPIC OF THE WEEK | Most Liked Paper on BioFingertips

This week, the most liked paper on BioFingertips is: “Epidemiology of cardiovascular disease and diabetes in 2026: expanding prevalence, escalating costs, and the limits of contemporary prevention.”

The 2026 AHA statistics reveal that cardiovascular disease has shifted from an acute condition to a chronic, systemic burden affecting nearly half of US adults.

Despite falling age-adjusted mortality, prevalence keeps rising due to earlier risk factor onset and longer survival, pushing annual healthcare costs.

Diabetes, hypertension, and metabolic dysfunction continue worsening despite available treatments, pointing to implementation failures rather than gaps in pharmacology. The authors conclude that lasting progress requires systemic prevention, integrated care, and coordinated health policy.

Being the most liked paper reflects what resonated most with healthcare professionals this week.

On BioFingertips, likes help highlight what the community finds relevant in real time.

Read the paper here: https://t.co/dt4RH51ud7

#CardiovascularDisease #Cardiology #CoronaryHeartDisease #Hypertension #Diabetes #Epidemiology #PublicHealth #PreventiveCardiology #HealthcareEconomics #MedicalResearch
#CardiometabolicHealth #HeartStats

[BioFingertips @biofingertips]

BioFingertips democratizes scientific knowledge for the global healthcare community.
Search millions of articles, save your favorites, share with colleagues, and build private or public discussion groups.
Join the scientific social network built for you → https://t.co/HhJ0zdFX7I
#BioFingertips #MedTwitter #Science

[BioFingertips @biofingertips]

BioFingertips democratizes scientific knowledge for the global healthcare community.
Search millions of articles, save your favorites, share with colleagues, and build private or public discussion groups.
Join the scientific social network built for you → https://t.co/HhJ0zdFX7I

#BioFingertips #MedTwitter #Science

[BioFingertips @biofingertips]

BioFingertips democratizes scientific knowledge for the global healthcare community.

Search millions of articles, save your favorites, share with colleagues, and build private or public discussion groups.

Join the scientific social network built for you → https://t.co/LhPvhLFJcP

#BioFingertips #MedTwitter #Science

[BioFingertips @biofingertips]

HOT TOPIC OF THE WEEK | Most Liked Paper

Rivaroxaban vs. warfarin in patients with AF + bioprosthetic mitral valve:

• Noninferior for major outcomes
• Lower stroke incidence
• Lower major bleeding

This is what resonated most with healthcare professionals this week on BioFingertips.

Read it here:
https://t.co/1nH78cRqG7

#BioFingertips #HotTopicOfTheWeek #Cardiology #AtrialFibrillation #HealthcareProfessionals

[BioFingertips @biofingertips]

There are millions of scientific papers available.

That was never the problem.

The problem is how long it takes to find what matters.
How difficult it is to filter relevance.
How disconnected information still is.

BioFingertips changes that!

[BioFingertips @biofingertips]

Searching for scientific information shouldn’t feel like this.

BioFingertips was built to simplify this experience.

🔎 Explore a better way: https://t.co/NYCUH1EkXb

[BioFingertips @biofingertips]

What can healthcare professionals do on BioFingertips?

This short video walks through the main features currently available on the platform, including:

• Searching and exploring scientific publications.
• Interacting with research through likes, comments, ratings, and shares.
• Creating public or private groups around specific topics.
• Connecting through direct chat with other healthcare professionals.
• Showcasing the scientific papers you have authored or contributed to through the "My Publications" feature.

BioFingertips is designed to make scientific information easier to access, discuss, and connect around.

🔎 Explore the platform: https://t.co/elAVvH4IFK

#BioFingertips #HealthcareProfessionals #MedicalResearch #DigitalHealth #ScientificInformation #HealthTech #OpenScience

[BioFingertips @biofingertips]

HOT TOPIC OF THE WEEK | Best Qualified Paper on BioFingertips

This week’s best qualified paper on BioFingertips was: “Efficacy of lisdexamphetamine to improve the behavioural and cognitive symptoms of attention deficit hyperactivity disorder: treatment monitored by means of the AULA Nesplora virtual reality test.”

In this study of 85 patients aged 6-16 years with ADHD, lisdexamphetamine treatment led to significant improvements in selective and sustained attention, attention focus quality, and hyperactivity, with moderate improvements in impulsivity.

The study also highlights the potential of the AULA Nesplora virtual reality test as an objective tool to monitor cognitive and behavioural responses to treatment.

Being the best qualified paper reflects what healthcare professionals on BioFingertips recognized as high-quality and clinically meaningful evidence.

Through the rating feature, the BioFingertips community helps signal which research deserves greater visibility.

Read the paper here:

https://t.co/naQQs8SzCj

#BioFingertips #HotTopicOfTheWeek #HealthcareProfessionals
#ADHD #MentalHealthResearch #Neuroscience
#EvidenceBasedMedicine #DigitalHealth #ScientificInformation

[BioFingertips @biofingertips]

BioFingertips just became more powerful.

Groups and Chat are here.

Are you in?

#BioFingertips #HealthcareProfessionals #HealthTech

[BioFingertips @biofingertips]

Science doesn’t move forward alone.

It moves through exchange.

Next week, BioFingertips takes another step in transforming how healthcare professionals connect around scientific information.

Stay tuned.

#BioFingertips #HealthcareProfessionals #DigitalHealth #ScientificCommunity

[BioFingertips @biofingertips]

HOT TOPIC OF THE WEEK | Most Commented Paper

"GLP1-1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta-analysis of randomised controlled trials and cohort studies."

GLP-1RAs may:
• Improve walking distance.
• Reduce lower extremity amputation risk.
• Show strongest limb benefit with semaglutide & tirzepatide.

This meta-analysis in T2D + PAD sparked the most discussion this week on BioFingertips.

Join the conversation:

https://t.co/W5f6aMwCaG

#BioFingertips #HotTopicOfTheWeek #GLP1 #Type2Diabetes #HealthcareProfessionals

[BioFingertips @biofingertips]

HOT TOPIC OF THE WEEK | Most Shared Paper

The SEMALEAN study on semaglutide 2.4 mg:
• 13% weight loss at 12 months.
• Significant fat mass reduction.
• Improved muscle strength.
• Reduced sarcopenic obesity.

This is what healthcare professionals chose to share this week on BioFingertips.

Read it here:

https://t.co/PIac1YWrHx

#BioFingertips #HotTopicOfTheWeek #Semaglutide #GLP1 #HealthcareProfessionals

[BioFingertips @biofingertips]

NEW FEATURE | Why Isn’t Your Research Visible?

You’ve written papers.
You’ve contributed to science.
You’ve advanced knowledge.

So why isn’t your research part of your professional identity online?

With our new feature, healthcare professionals can now link the scientific papers they have authored or co-authored directly to their BioFingertips profile.

Because producing science is not enough.
It should be visible.
It should be connected.
It should be recognized.

BioFingertips is not just where you access scientific information - it’s where your contribution becomes part of the conversation.

🔎 Add your publications to your profile today: https://t.co/GuDZ6FlJi8

#BioFingertips #HealthcareProfessionals #MedicalResearch
#ScientificCommunity #DigitalHealth #OpenScience
#AcademicMedicine #ResearchVisibility #HealthTech

[BioFingertips @biofingertips]

HOT TOPIC OF THE WEEK

This week’s best qualified paper on BioFingertips: Comparison of cardiovascular outcomes between once-weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States.

In >75,000 patients, semaglutide showed a 22% lower risk of MACE compared with dulaglutide.

This is what healthcare professionals rated highest this week.

Read it here:

https://t.co/K3Rtv1vD2k

#BioFingertips #HotTopicOfTheWeek #GLP1 #Type2Diabetes #ASCVD #HealthcareProfessionals

[BioFingertips @biofingertips]

Have you ever wondered why finding evidence takes so long - when it doesn’t have to?

[BioFingertips @biofingertips]

HOT TOPIC OF THE WEEK

Most liked paper on BioFingertips:

Safety and equity in scaling minimally invasive surgery worldwide in 109 countries using cholecystectomy as a tracer procedure: a prospective cohort study.

A powerful study showing that safer surgery depends more on training, safety systems, and diagnostics than on country income level.

Read it here:

https://t.co/nqQ6JfnQGG

#BioFingertips #HotTopicOfTheWeek #GlobalSurgery #PatientSafety #HealthcareProfessionals